EOC Pharma acquires exclusive development and commercialization rights to ABI-009 in Greater China Aadi will receive an upfront payment, regulatory and ... Read More

Rolling submission of U.S. FDA New Drug Application initiated Long-term follow-up data released at ASCO 2020 for AMPECT ... Read More

Business Wire article link: Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa   Highlights: ... Read More